Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol TOI
- Company The Oncology Institute, Inc.
- Price $3.66
- Changes Percentage -7.93
- Change -0.315
- Day Low $3.57
- Day High $3.99
- Year High $4.88
- Year Low $0.13
- Market Cap $356,617,370
- Price Avg 50 EMA (D) $3.76
- Price Avg 200 EMA (D) $2.71
- Exchange NASDAQ
- Volume 3,861,190
- Average Volume 1,996,079
- Open $3.89
- Previous Close $3.97
- EPS -0.67
- PE -5.46
- Earnings Announcement 2025-11-13 21:00:00
- Shares Outstanding $97,569,732
Company brief: THE ONCOLOGY INSTITUTE, INC. (TOI )
- Healthcare
- Medical - Care Facilities
- Dr. Daniel Virnich FACHE, M.D., MBA
- https://theoncologyinstitute.com
- US
- N/A
- 06-04-2020
- US68236X1000
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
